HomeCompareBPSR vs EQR

BPSR vs EQR: Dividend Comparison 2026

BPSR yields 3333.33% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPSR wins by $1244041712890.35M in total portfolio value
10 years
BPSR
BPSR
● Live price
3333.33%
Share price
$0.06
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1244041712890.40M
Annual income
$1,174,716,366,071,938,000.00
Full BPSR calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — BPSR vs EQR

📍 BPSR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPSREQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPSR + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPSR pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPSR
Annual income on $10K today (after 15% tax)
$283,333.33/yr
After 10yr DRIP, annual income (after tax)
$998,508,911,161,147,300.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, BPSR beats the other by $998,508,911,161,142,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPSR + EQR for your $10,000?

BPSR: 50%EQR: 50%
100% EQR50/50100% BPSR
Portfolio after 10yr
$622020856445.22M
Annual income
$587,358,183,035,971,700.00/yr
Blended yield
94.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

BPSR
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPSR buys
0
EQR buys
0
No recent congressional trades found for BPSR or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPSREQR
Forward yield3333.33%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1244041712890.40M$47.8K
Annual income after 10y$1,174,716,366,071,938,000.00$5,475.61
Total dividends collected$1239274250481.68M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BPSR vs EQR ($10,000, DRIP)

YearBPSR PortfolioBPSR Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$344,033$333,333.33$11,380$679.82+$332.7KBPSR
2$11,085,665$10,717,549.33$13,014$837.25+$11.07MBPSR
3$334,616,633$322,754,971.08$14,961$1,036.20+$334.60MBPSR
4$9,462,934,690$9,104,894,892.71$17,297$1,289.22+$9462.92MBPSR
5$250,766,259,005$240,640,918,887.41$20,121$1,613.15+$250766.24MBPSR
6$6,228,082,462,189$5,959,762,565,053.11$23,561$2,030.84+$6228082.44MBPSR
7$144,998,525,500,125$138,334,477,265,582.72$27,783$2,573.54+$144998525.47MBPSR
8$3,165,074,899,913,431$3,009,926,477,628,297.00$33,013$3,284.39+$3165074899.88MBPSR
9$64,790,043,755,570,470$61,403,413,612,663,110.00$39,547$4,223.51+$64790043755.53MBPSR
10$1,244,041,712,890,398,500$1,174,716,366,071,938,000.00$47,791$5,475.61+$1244041712890.35MBPSR

BPSR vs EQR: Complete Analysis 2026

BPSRStock

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Full BPSR Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this BPSR vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPSR vs SCHDBPSR vs JEPIBPSR vs OBPSR vs KOBPSR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.